P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

South Korea · Delayed Price · Currency is KRW

1,802.00

-8.00 (-0.44%)

At close: Nov 13, 2026

Market Cap	52.04B -32.0%
Revenue (ttm)	23.67B +8.6%
Net Income	3.73B -49.5%
EPS	129.23 -49.5%
Shares Out	28.88M
PE Ratio	13.94
Forward PE	n/a
Dividend	50.00 (2.78%)
Ex-Dividend Date	Dec 29, 2026

Volume	3,776
Open	1,801.00
Previous Close	1,810.00
Day's Range	1,797.00 - 1,816.00
52-Week Range	1,292.00 - 2,730.00
Beta	0.70
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About P&K Skin Research Center

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded in 201... [Read more]

Industry Commercial Physical and Biological Research

Founded 2010

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 347740

Full Company Profile

Financial Performance

In 2025, P&K Skin Research Center's revenue was 22.78 billion, an increase of 27.66% compared to the previous year's 17.85 billion. Earnings were 4.69 billion, a decrease of -19.45%.

Financial Statements